Published in Proc Natl Acad Sci U S A on February 01, 1993
Mutational spectra of human cancer. Hum Genet (2009) 2.26
Base pair conformation-dependent excision of benzo[a]pyrene diol epoxide-guanine adducts by human nucleotide excision repair enzymes. Mol Cell Biol (1997) 1.31
Human lung cancer and p53: the interplay between mutagenesis and selection. Proc Natl Acad Sci U S A (2000) 1.06
Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokers. Br J Cancer (2002) 0.98
Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. J Clin Invest (2012) 0.95
p53 alterations in human squamous cell carcinomas and carcinoma cell lines. Am J Pathol (1993) 0.93
Mechanisms of oral carcinogenesis induced by dibenzo[a,l]pyrene: an environmental pollutant and a tobacco smoke constituent. Int J Cancer (2013) 0.92
Characterization of Somatic Mutations in Air Pollution-Related Lung Cancer. EBioMedicine (2015) 0.92
A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Environ Health Perspect (1998) 0.91
Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors. Environ Health Perspect (2009) 0.90
NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones. Br J Cancer (1998) 0.89
TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts. Mutat Res (2015) 0.89
Environmental exposure of the mouse germ line: DNA adducts in spermatozoa and formation of de novo mutations during spermatogenesis. PLoS One (2010) 0.88
Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines. Cancer Growth Metastasis (2015) 0.84
Chemopreventive effects of sarcotriol on ultraviolet B-induced skin tumor development in SKH-1 hairless mice. Mar Drugs (2007) 0.83
VILIP-1 expression in vivo results in decreased mouse skin keratinocyte proliferation and tumor development. PLoS One (2010) 0.81
Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ Health Perspect (1997) 0.79
Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6). Mol Carcinog (2014) 0.77
Exposure of Human Lung Cells to Tobacco Smoke Condensate Inhibits the Nucleotide Excision Repair Pathway. PLoS One (2016) 0.75
Benzo[a]pyrene, aflatoxine B₁ and acetaldehyde mutational patterns in TP53 gene using a functional assay: relevance to human cancer aetiology. PLoS One (2012) 0.75
Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland. Br J Cancer (1999) 0.75
Mechanism of error-free replication across benzo[a]pyrene stereoisomers by Rev1 DNA polymerase. Nat Commun (2017) 0.75
p53 mutations in human cancers. Science (1991) 31.96
Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59
Mutations in the p53 gene occur in diverse human tumour types. Nature (1989) 13.62
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A (1991) 6.42
Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (1991) 6.16
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (1991) 6.04
Tumor suppressor genes. Science (1991) 5.72
Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science (1990) 5.47
Monoclonal antibody analysis of p53 expression in normal and transformed cells. J Virol (1986) 3.72
Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci U S A (1991) 3.45
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene (1990) 2.97
Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1991) 2.86
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene (1992) 2.64
p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res (1991) 2.09
Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci U S A (1990) 2.07
Analysis of p53 mutants for transcriptional activity. Mol Cell Biol (1991) 1.73
p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res (1992) 1.72
Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet (1992) 1.53
The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene (1991) 1.51
p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res (1991) 1.48
Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res (1991) 1.32
Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene (1991) 1.32
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res (1991) 1.30
Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines. Am J Pathol (1991) 1.29
Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer (1991) 1.24
Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenous aprt gene in CHO cells. Somat Cell Mol Genet (1988) 1.21
Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. Proc Natl Acad Sci U S A (1987) 1.19
Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. Proc Natl Acad Sci U S A (1990) 1.11
Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinog (1991) 1.05
Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res (1991) 1.02
Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates. Cancer Res (1992) 0.94
Altered p53 gene structure and expression in human epithelial cells after exposure to nickel. Cancer Res (1992) 0.91
Dose-dependent differences in the profile of mutations induced by an ultimate carcinogen from benzo[a]pyrene. Proc Natl Acad Sci U S A (1991) 0.89
Overlapping loss of heterozygosity by mitotic recombination on mouse chromosome 7F1-ter in skin carcinogenesis. Proc Natl Acad Sci U S A (1991) 0.89
Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors. Mol Carcinog (1992) 0.84
Benzo[a]pyrene-induced skin damage and tumor promotion in the mouse. Carcinogenesis (1991) 0.82
Chemical induction of oncogene mutations and growth factor activity in mouse skin carcinogenesis. Environ Health Perspect (1989) 0.81
Metastasis from squamous cell carcinomas of SENCAR mouse skin produced by complete carcinogenesis. Cancer Lett (1987) 0.79
Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature (2005) 10.04
Plasmid-determined tetracycline resistance in Streptococcus faecalis: evidence for gene amplification during growth in presence of tetracycline. Proc Natl Acad Sci U S A (1975) 4.21
Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation (1993) 3.68
Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors. Pflugers Arch (1972) 3.46
Prevalence and genetic diversity of coronaviruses in bats from China. J Virol (2006) 3.37
The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res (1999) 2.56
Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J (2001) 2.30
Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem (1998) 1.94
Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog (1991) 1.87
Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol (1996) 1.86
Host preferences of tsetse (Diptera: Glossinidae) based on bloodmeal identifications. Med Vet Entomol (1998) 1.82
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci U S A (1995) 1.76
New selective inhibitors of the transmembrane Ca conductivity in mammalian myocardial fibres. Studies with the voltage clamp technique. Experientia (1972) 1.68
Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc Natl Acad Sci U S A (1993) 1.66
Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol (1997) 1.63
Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science (1981) 1.63
Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet (1994) 1.63
Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci U S A (2001) 1.60
Activation of the small GTPase Ral in platelets. Mol Cell Biol (1998) 1.58
Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments. Mol Cell Biol (1998) 1.56
The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet (1999) 1.56
The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Hum Pathol (1995) 1.56
Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Mol Carcinog (2001) 1.56
11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology (1998) 1.56
Evaluation of renal biopsy samples of patients with diabetic nephropathy. Intern Med (2001) 1.52
Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Proc Natl Acad Sci U S A (1980) 1.47
Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China. J Virol (2007) 1.44
Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Oncogene (1992) 1.41
An easy-to-perform test to help confirm intravascular placement of pediatric intravenous lines. Anesth Analg (1995) 1.40
T-cell lymphoma lines derived from rat thymomas induced by Moloney murine leukemia virus: phenotypic diversity and its implications. J Virol (1990) 1.39
Peripheral autonomic potentials in primary headache and drug-induced headache. Cephalalgia (1998) 1.39
Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg (1989) 1.37
Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res (1995) 1.36
RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene (1996) 1.35
Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res (1994) 1.33
Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol (1996) 1.33
Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer (2000) 1.32
Apoptosis and hematopoiesis in murine fetal liver. Blood (1993) 1.31
Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J Natl Cancer Inst (2000) 1.31
Selective inhibition of the transmembrane Ca conductivity of mammalian myocardial fibres by Ni, Co and Mn ions. Pflugers Arch (1973) 1.30
Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. Cancer Res (2001) 1.29
Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines. Am J Pathol (1991) 1.29
Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells. Proc Natl Acad Sci U S A (2001) 1.26
Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer (1998) 1.25
E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev (2000) 1.20
Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology (2007) 1.20
Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. Proc Natl Acad Sci U S A (1987) 1.19
Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res (1989) 1.19
Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol (1997) 1.17
Permanent Genetic Resources added to Molecular Ecology Resources Database 1 May 2009-31 July 2009. Mol Ecol Resour (2009) 1.15
Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans. Vaccine (1997) 1.14
Conventional PKC-alpha, novel PKC-epsilon and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3T3 fibroblasts. J Biol Chem (1997) 1.14
Immunohistochemical analysis of p53 expression in human pancreatic carcinomas. Arch Pathol Lab Med (1994) 1.13
Double atrial septum with persistent interatrial space and transient ischaemic attack. Eur J Echocardiogr (2008) 1.12
Tsetse control in cattle from pyrethroid footbaths. Prev Vet Med (2006) 1.11
Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res (1991) 1.11
Phospholipase D stimulation by receptor tyrosine kinases mediated by protein kinase C and a Ras/Ral signaling cascade. J Biol Chem (1999) 1.10
Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur J Immunol (1999) 1.09
Molecular cloning and analysis of nre, the major nitrogen regulatory gene of Penicillium chrysogenum. Curr Genet (1995) 1.08
Induction of dark keratinocytes by 12-O-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency. Carcinogenesis (1980) 1.08
Studies on the mechanisms involved in multistage carcinogenesis in mouse skin. J Cell Biochem (1982) 1.07
Aneuploidy, an early event in mouse skin tumor development. Carcinogenesis (1986) 1.06
Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol (1994) 1.06
The proprotein convertases furin and PACE4 play a significant role in tumor progression. Mol Carcinog (2000) 1.05
Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior. Int J Cancer (1999) 1.05
Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice. Cancer Res (1992) 1.05
Effective doses to members of the public from the diagnostic application of ionizing radiation in Germany. Eur Radiol (1997) 1.05
Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol (2000) 1.04
Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. Cancer Res (1999) 1.04
A direct cytogenetic technique for mouse skin carcinomas and papillomas. Cancer Genet Cytogenet (1986) 1.03
Regulation of glycerol metabolism in Enterococcus faecalis by phosphoenolpyruvate-dependent phosphorylation of glycerol kinase catalyzed by enzyme I and HPr of the phosphotransferase system. J Bacteriol (1993) 1.02
Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res (1991) 1.02
The 30-Hz flicker cone ERG for monitoring the early course of central retinal vein occlusion. Acta Ophthalmol Scand (2000) 1.02
Early [(11)C]Flumazenil/H(2)O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke (2000) 1.01
Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide. Cancer Res (1986) 1.01
Potentiation of diffuse lung damage by oxygen: determining variables. Am Rev Respir Dis (1981) 1.00
Cataract patients in a defined Swedish population, 1986 to 1990. V. Postoperative retinal detachments. Arch Ophthalmol (1996) 1.00
Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res (1999) 1.00
ABC transporters in the CNS - an inventory. Curr Pharm Biotechnol (2011) 1.00
Subpopulations of primary adult murine epidermal basal cells sedimented on density gradients. Cell Tissue Kinet (1990) 1.00
Standardised tests in mice and cattle for the detection of drug resistance in tsetse-transmitted trypanosomes of African domestic cattle. Vet Parasitol (2001) 0.99
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. Cell Death Differ (2012) 0.99
Potentiation of butylated hydroxytoluene-induced acute lung damage by oxygen. Cell kinetics and collagen metabolism. Am Rev Respir Dis (1983) 0.99
Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke (1998) 0.99
Preparation of antigastric cancer monoclonal antibody MGb2-mitomycin C conjugate with improved antitumor activity. Bioconjug Chem (1991) 0.98
Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity. Cancer Epidemiol Biomarkers Prev (1998) 0.97
Stereologic baseline data of normal human epidermis. J Invest Dermatol (1977) 0.97
Metaplastic conversion of the differentiation pattern in oral epithelia affected by leukoplakia simplex. A stereologic study. Pathol Eur (1976) 0.97
The changing distribution of two riverine tsetse flies over 15 years in an increasingly cultivated area of Burkina Faso. Bull Entomol Res (2001) 0.97
Analysis of genomic rearrangement and subsequent gene deletion of the attenuated Orf virus strain D1701. Virus Res (1998) 0.96
Magnetic resonance arthrography applied to the diagnosis of intraarticular adhesions of the temporomandibular joint. Int J Oral Maxillofac Surg (2005) 0.96